133 related articles for article (PubMed ID: 23375796)
1. Synthesis and antibacterial activity of 9-oxime ether non-ketolides, and novel binding mode of alkylides with bacterial rRNA.
Liang JH; Lv W; Li XL; An K; Cushman M; Wang H; Xu YC
Bioorg Med Chem Lett; 2013 Mar; 23(5):1387-93. PubMed ID: 23375796
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides.
Liang JH; An K; Lv W; Cushman M; Wang H; Xu YC
Eur J Med Chem; 2013 Jan; 59():54-63. PubMed ID: 23202851
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of novel 8a-aza-8a-homoerythromycin A ketolides.
Pavlović D; Mutak S
J Med Chem; 2010 Aug; 53(15):5868-80. PubMed ID: 20684614
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activities of 6-O-methylerythromycin A 9-O-(3-aryl-2-propenyl) oxime ketolide, 2,3-enol ether, and alkylide analogues.
Liang JH; Dong LJ; Wang H; An K; Li XL; Yang L; Yao GW; Xu YC
Eur J Med Chem; 2010 Sep; 45(9):3627-35. PubMed ID: 20627377
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens.
Ma CX; Lv W; Li YX; Fan BZ; Han X; Kong FS; Tian JC; Cushman M; Liang JH
Eur J Med Chem; 2019 May; 169():1-20. PubMed ID: 30852383
[TBL] [Abstract][Full Text] [Related]
6. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens.
Nomura T; Yasukata T; Narukawa Y; Uotani K
Bioorg Med Chem; 2005 Nov; 13(21):6054-63. PubMed ID: 15994088
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial evaluation of a novel series of 10-hydroxyl ketolide derivatives.
Jiang JW; Sun Y; Nie Y; Zhi HJ; Zhang XJ; Li X; Sun HP; You QD
Bioorg Med Chem Lett; 2013 Jun; 23(11):3452-7. PubMed ID: 23591116
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides.
Xu Y; Chen X; Zhu D; Liu Y; Zhao Z; Jin L; Liu C; Lei P
Eur J Med Chem; 2013 Nov; 69():174-81. PubMed ID: 24021890
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Sugimoto T; Shimazaki Y; Manaka A; Tanikawa T; Suzuki K; Nanaumi K; Kaneda Y; Yamasaki Y; Sugiyama H
Bioorg Med Chem Lett; 2012 Sep; 22(17):5739-43. PubMed ID: 22858102
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains.
Chen XZ; Xu P; Liu L; Zheng D; Lei PS
Eur J Med Chem; 2011 Jan; 46(1):208-17. PubMed ID: 21130543
[TBL] [Abstract][Full Text] [Related]
11. Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex.
Nishimoto A; Narita K; Ohmoto S; Takahashi Y; Yoshizumi S; Yoshida T; Kado N; Okezaki E; Kato H
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1120-7. PubMed ID: 11558597
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antibacterial activity of novel ketolides bearing an aryltetrazolyl-substituted alkyl side chain.
Song QL; Guo BQ; Zhang W; Lan P; Sun PH; Chen WM
J Antibiot (Tokyo); 2011 Aug; 64(8):571-81. PubMed ID: 21772308
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-bactericidal activity relationships of novel 9-oxime ketolides and reductive epimers of acylides.
Tian JC; Han X; Lv W; Li YX; Wang H; Fan BZ; Cushman M; Liang JH
Bioorg Med Chem Lett; 2017 Apr; 27(7):1513-1524. PubMed ID: 28256375
[TBL] [Abstract][Full Text] [Related]
14. [Advance in synthesis of ketolides, a new class of erythromycin derivatives].
Lei PS; Xu P; Liu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):467-73. PubMed ID: 15379279
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of two and antibacterial activity of one novel oxime ether derivatives of erythromycin A.
Dondas HA; Yaktubay N
Farmaco; 2003 Oct; 58(10):1011-5. PubMed ID: 14505731
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Nam G; Kang TW; Shin JH; Choi KI
Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Xu P; Liu L; Chen XZ; Li Y; Liu J; Jin ZP; Wang GQ; Lei PS
Bioorg Med Chem Lett; 2009 Aug; 19(15):4079-83. PubMed ID: 19560350
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships and mechanism of action of macrolides derived from erythromycin as antibacterial agents.
Liang JH; Han X
Curr Top Med Chem; 2013; 13(24):3131-64. PubMed ID: 24200358
[TBL] [Abstract][Full Text] [Related]
19. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
Pavlović D; Fajdetić A; Mutak S
Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides.
Hu L; Lan P; Song QL; Huang ZJ; Sun PH; Zhuo C; Wang Y; Xiao S; Chen WM
Eur J Med Chem; 2010 Dec; 45(12):5943-9. PubMed ID: 20970894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
